Upload
dsfg-dsyfdxcghj
View
219
Download
0
Embed Size (px)
Citation preview
7/22/2019 3514-Ghid Inv Phh
1/252
GHID
DE SUPRAVEGHERE I CONTROLN INFECIILE NOSOCOMIALE
EDIIA I
Editarea lucrrii a fost realiat cu suportul acordat de ctre poporul american prin
intermediul Ageniei Statelor Unite pentru Devoltare Internaional (USAID).Ministerul Sntii i Proiectul Prevenirea HIV/SIDA i Hepatitelor Virale B i C poartresponsabilitate pentru coninutul acestui Ghid.Ghidul nu reflect opiniile USAID sau ale Guvernului Statelor Unite ale Americii.
Chiinu - 2008
7/22/2019 3514-Ghid Inv Phh
2/252
7/22/2019 3514-Ghid Inv Phh
3/252
Ministerul sntii al republicii Moldovaproiectul usaid prevenirea Hiv/sida
i Hepatitelor virale b i c
GHID
DE SUPRAVEGHERE I CONTROLN INFECIILE NOSOCOMIALE
EDIIA I
c : V. PRISACARI,f. ., h, om m
ch 2008
7/22/2019 3514-Ghid Inv Phh
4/252
cZu 616.9-022G 49
GHIDUL DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALEa fost aprobat de ctre Consiliul de Eperi al Ministerului Sntii al Republicii Moldova,
proces-verbal nr. 5 din 28 noiembrie 2008.Coordonator tiinic principal:
v p h m, f , om m,f emg u s M Fm n tm, mg M s r M,
Consultant internaional:
lm Z h m, f , m am n r, f emg am
s i. Mh sk pg, mg g n v F r.
Receneni ociali:
v b h m, f px c n - p M p M s r M
vm cz m, f chg . 2 u s M Fm n tm,s hg M s r M
Responsabili de editarea lucrrii:
v p h m, f , om m,f emg u s M Fm n tm, s mg M s r M,
c rm m, f Mg dmc if p ag s u dz i p Hiv/sida H v b c
v a c if p ag s
u dz i p Hiv/sida H v b c
isbn 978-9975-106-19-1
Descrierea CIP a Camerei Naionale a Crii
Gh gh f m/ . .: v. p. ch.: e-v.i.srl., 2008 . 248 .
isbn 978-9975-106-19-11000 x.
616.9-022
7/22/2019 3514-Ghid Inv Phh
5/252
Gh m , m m- mg, mg, hg, mg, -gg,, g, m m .
e f z m m ag
s u dz i (usaid).M s p p Hiv/sida H v b c Gh.
Gh usaid G s u am.
e - z g G h M s rM dz . 234 29.05.2007 . 84 04.03.2008
b G vm ,
sg r vm v p s mg Ms, f emg
u s M Fm n tm,f , h m,
M amh s d m ,
l v f d s M p M s
sg og f j d p s M p M s
v s f d ag s M sf Ghgh s Ms gh f Hiv/sida,
pm- c n -p M p
c s s Ms g mg,
c n -p Mp, f , h m
f pg s mg, f Mg,img vg usMF n tm, f
, mv F s Ms gg,
f o Gg u s M Fm ,, n tm, f , h m
i o v cm n ag M
c rm Mg dm c if, p usaid /p Hiv/sida H v b c
p usaid pHH, 2008
7/22/2019 3514-Ghid Inv Phh
6/252
ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
LISTA ABREVIERILOR
BAAR --zCDC c c b s u (a)
CMP c M pCNPMP c n -p M pDRAM z mGDAM g mHIV m mHVB h bHVC h cIMS m-IN f mISP f -ISPN f - mITU f NNIS n nm if s (sua)OMS ogz M sPDI PMD m PU SA TB zTBA zTBL z UV VHB h bVAC h cCSSIN m gh f mCS cm DS
zf z
7/22/2019 3514-Ghid Inv Phh
7/252
5
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
capitolul 1.POLITICA I STRATEGIA DE ORGANIzARE
A CONTROLULUI INFECIILOR N INSTITUIILE MEDICALE ..............9
1.1. c gh f m m- r M (v. p) ................................................9
1.2. p g gz f m (v. p) ............. 16
1.3. em gz f m. (l.v, s. og, e. b) .......................................................................................................................... 18
1.3.1DirijareasistemuluiCI...............................................................................................................................................18
1.3.2Organizareasistemuluidesupraveghereepidemiologic,studiereafactorilor deriscielaborareaplanuluidemsuri............................................................................................................19
1.3.3AsigurareaCIcuserviciidelaboratormicrobiologic...................... ...................... ....................... .................... 19
1.3.4 Implementareamsurilordeprolaxieicombatereconcrete................... ................... ................... ................... .... 19
1.3.5Suportuladministrativ..............................................................................................................................................19
1.4. cm n. s . (v.p, s.og) .................................................19
1.5. cm . s . (v. p, l. v, e.b)........... ...... ....... ....... .. 20
1.6. F mg . (v. p) ............................................................................................. 21
capitolul 2.
EPIDEMIOLOGIA INFECIILOR NOSOCOMIALE .................................... 252.1. d z f m. (v. p) ................................................................. 25
2.2. p g f m. (. pg) ........................................................... 25
2.3. emg f g m ................................................................................................. 29
2.3.1.InfeciacuHIV(t.Gheorghi)...................... ....................... ...................... ....................... ....................... ............. 29
2.3.2.Hepatiteleviraleparenterale(C.Spnu,P.Iarovoi,C.Rmi).................... ...................... ....................... .......... 36
2.4. if . ............................................................................................................................... 48
2.4.1.Infeciachirurgical.(V.Prisacari)...................... ....................... ...................... ....................... ....................... .......... 48 2.4.2.Infeciacilorrespiratoriiinferioare.(V.Prisacari)..................... ....................... ....................... ...................... ..... 57
2.4.3.Infeciacilorurinare.(V.Prisacari)....................... ....................... ...................... ....................... ...................... ....... 61
2.4.4.Infecianounscuilorialuzelor.(V.Prisacari)...................... ....................... ...................... ....................... . 65
2.5. a f m ...................................................................................................................................... 69
2.5.1.Infeciapediatric.(A.Cotelea)....................... ...................... ....................... ....................... ...................... .............. 69
2.5.2.Tuberculoza(A.Melnic,V.Crudu).................... ...................... ....................... ....................... ...................... .............. 73
2.6. e . .................................................................................................................................................. 77
2.6.1.Procedeeledeprevenieaexpuneriilarisc.(C.Spnu,P.Iarovoi,M.Apostol)..................... ...................... . 77
2.6.2.Tipuriledeaccidente(t.Gheorghia,Ec.Rotaru)...................... ...................... ....................... ....................... .... 79
2.6.3.Prevenireaaccidentelorialtortipurideexpunereprofesional(C.Spnu,P.Iarovoi,L.Iarovoi).......... 80
Cuprins
7/22/2019 3514-Ghid Inv Phh
8/252
ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
capitolul 3.ASIGURAREA REGIMULUI SANITARO-ANTIEPIDEMIC ......................... 83
3.1. s j m m. (a. M) .................................................................... 83
3.2. dzf (m hm). (v. , e. b,) ...... ....... ....... ....... ...... ....... ....... ....... ....... ...... ..... 88
3.3. sz. (e. b, v. ) ................................................................................................................ 101
3.4. G z m. (v. p, e.lh) ...............................115
3.5. ag z m f. (v.H) ................................................132
3.6. Mz gm -m. (v. ) ....... ....... .133
capitolul 4.REzISTENA AGENILOR CAUzALI LA PREPARATELE ANTIVIRALE,ANTIBIOTICE I DEzINFECTANTE ......................................................... 151
4.1. rz . (c. s) .............................................................................................151
4.2. rz . (v. p) .............................................................................................................. 155
4.3. rz zf. (v. ) ......................................................................................................... 166
capitolul 5.IGIENA PERSONALULUI MEDICAL ......................................................... 19
5.1. ig m ( ). (e. b, v.) ....... ....... ...... ....... ....... ....... ....... ...... 169
5.2. p (pu) (e. r, Ghgh) ..........................................................177
5.3. imz m Hvb. (p.i, l. i) ....... ...... ....... ....... ....... ....... ...... ....... ... 179
5.4. M x x (l. i, e. r) ....................................................................180
5.5. c m z x (.Ghg, i.cmh) ........................182
5.6. Mz m f (c. s, t. H) ............ ..... 185
capitolul 6.CIRCUMSTANE SPECIFICE ....................................................................... 189
6.1. p gz f hg. (v.p) ..................189
6.2. p gz f gg. (v. F, v. a).................................................................................................................194
6.3. p gz f hmz. (v.p) .............200
6.4. p gz f . (.Ghgh, . pg) .............201
6.5. p gz f mg. (p. i) ....... ...... 207
6.6. p gz f f. (t. H) ....... ...... 214
6.7. p gz f . (v.p, v. a)...........................................................................................................215
6.8. p gz f m . (v. p, e. l) ................................................................................221
7/22/2019 3514-Ghid Inv Phh
9/252
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
capitolul 7.SUPRAVEGHERE EPIDEMIOLOGIC ........................................................ 225
7.1. s -mg s m f . (v. p, a. M)...............................................225
7.2. g, f m. (v.p) ............................................2267.3. exm m m m. (v.p) ...............................................227
7.4. og m f m (v.p, v. a) ...............................................................................................................229
ANExE ............................................................................................................. 235
ax 1. F g m m z x f Hiv h b c .......................235
ax 2. ah f m f Hiv .................................237ax 3. Fm mm fm f fx
- f Hiv ..........................................................................................................238
ax 4. Fm mm fm Hiv z z .................................................................................................................239
ax 5. F gh mg f hg .............................240
ax 6. ah mg f m ..................................................241
ax 7. p m z f m ........................243
ax 8. F gh ( m) .................................................................................................244
ax 9. F gh mg z f m ..................................................................................................245
ax 10. F gh mg z f m z ....................247
7/22/2019 3514-Ghid Inv Phh
10/252
7/22/2019 3514-Ghid Inv Phh
11/252
9
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
capitolul i.POLITICA I STRATEGIA DE ORGANIzARE
A CONTROLULUI INFECIILOR
N INSTITUIILE MEDICALE
1.1 Conceptul cu privire la supravegherea i controlulinfeciilor nosocomiale n cadrul instituiilor medico-sanitaredin Republica Moldova
Acualiaea
g m f m (in) . e g, mj m, -m g m, m z m mj m (6, 7, 8, 10, 29).
cfm x oMs f m g m f, fz z z m, m f fz m m g f,
f mm mm m .cfm x oMs, f 14 m, g f
m g 8,0% - 21,0% m . e mj m m z ; 75,0%
hg (3, 4, 5, 11, 23).o m g z h b
c, f Hiv/sida, z, mz .d m m m m mx g f -
, , m, , , f . e gj f gz 300-350 z j.
r M f m m . t, m m f m -
g 66,6% hg, 16,6% - m 14,5% - (10).
fm r M m f m 2006 : hg 1,8 1000 , f g - 2,9 1000 -, z 3,9 1000 , - 6,7 1000-.
t, oMs- g m r M m f m. u f m m hg 83,16 1000 (13).
p z g f m m, g z, z fm fm.
o g, m f m m, f,
m , g f z, g m m. m, e v suam g m f (27).
7/22/2019 3514-Ghid Inv Phh
12/252
10 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
e f z f z f z m , , , m , ,j.
t, fm g in z m, g m, m j in, f m
(mj g , g m z, f , m m m , m -, m m , fm,, h .).
cm - g z 5,6 35,4 z, f , m 14,07z (9, 10, 12, 13, 22, 24), , , g m m. sua, xm, g z 5 m $ (27).
u (12) m , g m m ispn m .ch m 16-23 m , f z , mm m , m f m in . r z
f 3-4 m m.
Particularitile epidemiologice
if m fm, mg g f m m m f .
m m f f m z gg, f (j, f, f xm, g, mz,ghz, h , f Hiv .), f m -.
o z mg fm m gh mg, m m g m, mxm
f, f , in, - .d g f m g
z h b c. f m g xm F r
1997-2001 h b 3%, Hvc 0,8%, mz 2,7% (28). g s m - g (1999) f h m 84
, 61 Hvb 23 Hvc. .. . (2003) m hg f hz h b, c -mg b fm 22,343,3% .
d f - (isp) m m m mx g
m, - (4). r M m - (2002) f g 214 z m - (1). cfm .. . (2002) fm gz 3,5% f -- m (ispn).
o zz isp mm g, g . l gz 140-150 mf isp, fz -m f gm, m f m, ,gg, m, m . (10).
t, f - z gm g mgm. cfm v. p, v. s (1999) m - g , isp f 27 mgm, gmz (62,3%), gmg (34,7%), (2,8%).
o g xm isp , g z m mgm -z , g, m , m s. m, s. hy, e. , mgm g pm, K, e-
7/22/2019 3514-Ghid Inv Phh
13/252
11
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
, e, a, c, s, p, p, e, Mg. (5, 20, 25, 29).
rz g (9, 14) m fm. d 132 mgm z m - hg m 29,5% z e. , 12,9% - s. m, 9,8% - s. , 9,8% - p. g-
, 8,3% - K. m, 6,8% - s. f, 4,5% - p. m, 3,8% s. m, 1,5% a mgm.o m mj z f m z (z) -
mgm f zf.cfm m m g f fm p-
m g, xm, - 50% z z f , 75%z f gm 42% f x, mgm g a- . f z f 88% z, f fxm - 96%, fxm
88%, fx 94%, fz 78%, gm 91%, x 53%, c-tmxz 88% (23).
u f l if g emg
usMF n tm m 57,0% - z , f 70,8%, 58,7%, m 66,8%, zm 55,0%, mgz 51,0%, f 41,4%.o z f p. g. t p. g ispn - z f 97,9%, f 58,1%, mgz 69,2%, 94,1%, m
100,0%, 84,0% z. d K. m - z- 82,0%, p. g 80,0%, c 75,0%, e. 64,0%, p. m
60,0%, s. m 52,0% (15).rz (z) f g
mm hz z m, mgm , z g, , hm zf.
cfm x m 50,0% z g z m.M m g m f, z fm z x g (23).
s- r M m 33,2% f - m g g m gm, iMs gg m g 5,0 15,0%.
t, 80,0% ispn m . a, m jm ispn mz f gm.
s m 20 z f zf (E.. , 1999).
d m, r M, m, , fz m z f zf.t, g mg f mz
m mgm g z f m (Gh.c ., 2003).
am z m x z hm fm , m h hm zf.
c m g m f m f .
cfm g (2) mg z f -
f h, m mm g, hg m (14). u f m 45% m g m (15).
7/22/2019 3514-Ghid Inv Phh
14/252
12 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
f m m m m f f (m, ,h) 40,0%, (f, ) 36,5%, f m () 12,5%, f g () 10,0% mg (mz) 0,1% (22).
cfm 1500 m 17 fm 20,8-45% (27). hmg in z m, m f -
m g m (.. ., 2003). if mm f m z (17).
m, m f in - j, m, mf,, m (1).
u m hz h b c z hmz. .. . (2003) m Hvb Hvc 67,2 48,5%, -, hmz m 6 , .. . (2003) m (=0,790,66) f hmfz m
h b c hmz s.-pg.cfm m m mj in m g mg. d xm gs, fm .. . (2002) m Hvb mg 40,0%, Hvc 39,0%.
.. . (2002) m z zg m j 3,5 m m mg .
u m, z m m -- m. ch f f cMp ch. s- (2002) m 6,8%, hg 5,7%, m 6,6% mg 8,8%.
a, m - mg in. gm m f:
- m mg mg m in m g;
- m mg, . am r M fz 11 406 mg 257 mg ;
- m m mg, g .
c - x z m in m. az m, h, - f g , f hg z m,m, g , . z -gm g m, hg g,m f, mjz m z in.
o m , z, m f m g m, f. p z m . d m m f gm m m.
a fm x f in f j m m.
7/22/2019 3514-Ghid Inv Phh
15/252
13
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
g ch (F r) 5945 z h b c, g 2000-2002, 306 , 5,1%, f m(.. ., 2003).
cfm (65) m f m mHvb 77,3%, Hvc 3,3%, z 5,5%, m 1,9%, m 8,2%
g 1,8%... . (2002) 61 g 3 (1999-2001) g m Hiv. vm - 35% z f m, 25% - m, 12% f 7%- fm.
a, m z m z in mg (Hvb, Hvc, f Hiv).
t, j g f m m rM f . 2008, f, m z mg in. e m g , zf, g, z m
f m . t fm g (27) 2 4% f h .p mm g m oMs . 2005
g u m g m m g. i G gmfm z gm m m m m m g . m f, r M m 30 2006 ogz M s m f m mm g m, m hmm, f f m-, g z m.
o m r M m , f - m m f m, m f m-g , m .
d o Ms n 140 30.04.98 d f m m -x f m m mg g gz gh mg fm , z x f m mg iMs, x scr, inn, iMs c ugh.
come exene n ne anare ror a raegherea onro nfeor no-
oomae n azre e nfe nooomae. proeee erae a eneor omormeae mrre fa n ar or e n ea neeaea n meamene,nrmenar mea, aaere aare n zn e gen a e a, energe eer, a-ene n emee e anazare a aee e. n nee iMs raonae n ome reee nn n ea cMp enr eaarea azror exeonae n e ooeaz earna a Ms.
a, gz m f gh f m (iMs) m m m.
tm g g iMs m, (/ z) m .
r f iMs f : x g f, f g f g.
7/22/2019 3514-Ghid Inv Phh
16/252
1 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
p m g f zz m -m :
- g m;
- ;
- gj -;
- ;- ;
- mz z x;
- mm gm j;
- g fz g ;
- g zf z m m;
- z z m f;
- z m.
d m m f m m, f iMs g. af mm gm f m z mx m m m, h.
i x z c z z Gh gh f m M s p- usaid p Hiv/sida h b c M , - perfecionareadocumentelornaionalevizndpracticilemedicalepentruareducerisculdecontractareainfeciilornosocomialeninstituiilemedicaleisusinereaimplementri iaces-torpractici.
p z m f m:
1. e mm gm gh mg f m r M.
2. rz mz m m f m, fm .
3. imm Gh gh f m m- r M.
4. i m mg .
5. pf m mg mgm f m gz m m h.
6. ifm mg iMs cMp f mg f m, gz x m m .
7. ogz hm x m gh f m z m.
8. c z h f m f m.
9. pf mg mg mg, f , g, z g z, g . Mg mg m g z , zf z z , g z in.
10. a g mg g fm fm .
7/22/2019 3514-Ghid Inv Phh
17/252
15
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
11. imm hg hg m g g m. s- , z m hgmz m in m h.
12. pf m g , zf z m gh .
13. e z f m, mg, m z f m.
Bibliograe
1. a v., s c., Mg M. . M. cg v ig, emg M-g r M. 26-27 m, 2003. v. 2b. ch, 2003. p. 139-142.
2. v. b, v. nhf, i. c, i. pgz. c m. 1997. n 4. p. 54-55.3. ch Y.s. ug s.W., Wg c.J., l s.s. Mgm f m f f wh -
mg g qfg // J f tm. 1998. 45 (4). p. 758-764.
4. e p., r b. r M s rm. 1993. 11 b (11). p. 901-908.5. G i., v c., M i. agg. 1990. v. 31 (8 s. n). p. 529-531.6. i a. bg, g, zg, mg. 1994. v. 39. n 3-4. p.
161-167.7. Jg Z., a c., M p. . pg. bg. 1991. n 5. p. 561-564.8. M M. b lam n M. 1993. n 5. p. 719-726.9. p t, p v. a usMF n tm.v.2. pm
(g, mg mgm). ch, 2001, . 211-215.10. p v. pm f m. c m, 2005, n 3, . 47-52.11. p v., b s., p t. sgh mg m r-
M. ch, 2000. p. 29-32.12. p v., Gh p., a c., p t. cg iv g, emg, M-
g pzg r M. ch, 1997. p. 227-229.13. p v., ph a., Jh c. b am M. m,
2005, n 2, . 73-86.14. p v., p t. M. cf. usMF n
tm, 21-22 m 1998. ch, 1998. p. 180.14.p v., r e. p mg f hg. b aM.
m, 2008, 2, . 13-22.15. p v., s s. b am M. m, 2006, n
3(7), . 261-270
16. .. . , 2002, . 9-13.17. .., .. ,
. ., 2003. . 175-176.
18. .. . ,
. .-, 2003, . 55-57.
19. .., .., .., ..
. ., 2002. .30-34
20. .., .. // . . 1993.
228 .
21. .., .., . ,
. . , 2003. . 182-185.
22. .., .., .. . . .,2002, . 43-50.
7/22/2019 3514-Ghid Inv Phh
18/252
1 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
23. . // . . Ame-
rican International Health Aliance, 2003.
24. .. , ,
, . _ ., 1999. . 196-197.
25. .., .., .. ,
. . , 2003. . 97-98.26. .., .. , .. . . .,
2002, . 50-53.
27. .., .., .. . //
. ., 2002., . 53-58.
28. .., .., .. . .,
2002., . 69-73.
29. .., .. . . ,
1989. 168 .
1.2 Politica i strategia de organizare a controlului infeciilorn instituiile medicale
c m f m jm XX m gm , m , f. pmgm m f m, s u am 1950-1960, m m, g f.
f u s, r M, m pgm fm f mj 80- . t f cm m f m, 1988 f m m Ms ussp p
g f . r M g z f m --
1989, m Ms rM n 242 08.02.89 p g f , m m gz f g z m m g, m m z hzf m f. p m fm g m (fm fm n 058/) g z f z f -.
t, f 90- (v. p ., 1997) m f cMp m m 10% f m-.
u mm gh f m r M g m o Ms n 140 30.04.1998 d fm m x f m, j , mg f m, m f m, g g f m, m xm z in, g m () m z.
px, f z f m- . d m , 30%,
(a. ph, 2004), 70% z m . e j m, 2006 14 - z f m, m m m 2 10 z in .
7/22/2019 3514-Ghid Inv Phh
19/252
1
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
p z z in g g z fm f (m), - g m m .
t n 140 g f m 400 m m mg g -gz gh mg f m , f g z m m f m. mm xm . n m- f m-mg. t, x (sua, M b, a, Fr ( nzk sk-pg), .) m m f m-mg m- gz m m in. m csi j z m- -mg, gz -gh f m .
u xm iMsp icdosM c s g -
gh -mg f m, z f g gm m .n m gz m m in,
gz m fz. cm x m z in. n m cMp - z x.
ig g f - m . t, , m isp , m 2/3 z f gm, f mz m, z/z f z, z 80-90%.
p m r M f mm m- gm m f m, m :
1. H cg Ms 24.06.2000 p gz m gh fm.
2. o Ms n 53 21.03.2000 d f rM(i m , zf z m.
3. H cg Ms 26.06.2001 p gz g m iMs.
4. o Ms n 327 04.10.2005 c mm hg f m m f m
m fm.5. i m Ms n 06-4/777 24.05.1991 d gz gm -
m zf m m mg.
6. H m f r M n 18 04.09.2006 d mm i f Hiv/sida m.
7. s sgh mg f Hiv/sida Ms n 20, 19.01.2007.
M m m z, Ms n 140 30.04.1998 d f m m x
f m. e pgm gh f m m m , z m.
7/22/2019 3514-Ghid Inv Phh
20/252
18 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
rz m g m, gmm , :
gm g m ;
g m, g m;
hm m;
g z m, j.t m m.d m f 30 2006 . M gz oMs
m M s rM, m i a m d oMs , f g - m.
l 29.06.2007 c M s c c gh f m m- r M, f m . 2007-2009, m m :
e mm m gh mg f
m, , m; rz mz m, Ms n 140 30.04.1998 m f m.
e mm gh gh f m m- r M.
ogz m z m f m. i, f m mg mgm
f m. ag hm x m gh f m
. imm gm gh mg f m.
e m mm pf m.
e z f m, .
1.3 Elemente de organizare a controlului infeciilor (CI)n instituiile medico-sanitare
iMs f m , g , m- .. f . p m, gz ci iMs, fm . t, x mmf g m ci iMs.
1.3.1 Dirijarea sistemului CIog j gh in iMs Comitetul
despital(CS). i g z . cm f cs z mm 1.5.
1.3.2 Organizarea sistemului de supraveghere epidemiologic,studierea factorilor de risc i elaborarea planului de msuri
Fg h ci mg . F z mg z mm 1.6.
7/22/2019 3514-Ghid Inv Phh
21/252
19
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
1.3.3 Asigurarea CI cu servicii de laborator microbiologics gm ci g mg
gm. e f m - mg -mg. mg.p z m z g
m, m z zf. p mm m fm.
1.3.4 Implementarea msurilor de prolaxie i combatere concretecmx m ci z z mg
m m m z z . iMs m-m m g m, m m mg; m z, z zf; m .p x m f g mm , ,
f .1.3.5 Suportul administrativ
s pgm ci m, m , mmg, m gj. e m - gm ci, . d , gm gh mg m z in.n m in m - gj z f z f m. z z z .
1.4 Comitetul naional de supraveghere i control n infeciilenosocomiale. Structura i responsabilitile
j m g f m gh mg f m m , g M s z cm , :
f m in;
Ms g f, m hg,
gg, .; gh mg in.cm f m f m.
Responsabiliti
1. cz gh mg f -m.
2. ez gh f m.3. ez gm gh mg f -
m.4. ez fz m, m gh gh
f m.
7/22/2019 3514-Ghid Inv Phh
22/252
20 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
5. ez m mz z gm g-h f m.
6. ez gm z m gh f m.
7. az z () m, z f m.
1.5 Comitetul de spital. Structura i funciile
cm gh f m cs - iMs z .
m cs : (m f j m ), mmg m mg, f, g, f, hg,, , mfg. cm cs m f -g mg. e m -m g, x j m.
cs iMs.
F cm : gzz gh in iMs,
m ;
m gh mg iMs mmg, m, m, h, .;
z m cMp m g g z in;
z z IMS cMp gh in z , g z ,gzz ghz in, gm m;
zz z c m , , , mg in iMs;
z iMs, zzz , z m mg c M z ;
gzz fz m m gh mg, m x in gj ;
z f in, z z fm f;
, z z gm in iMs, , m / , g f.
imm gm in j m mg: z x iMs z in, h g -
mg g;
m , h, f mg m iMs;
m m .
cs m iMs g, fm, m hg fm, hz m-, m h, m, m.
7/22/2019 3514-Ghid Inv Phh
23/252
21
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
1.6 Funciile epidemiologului de spital
s mg in z m f emg .
c z m mm f mg iMs
Ms n 140 30.04.1998 d f m m x in. d-m , g m m in, f mg , gm, , f .
i f mg m mg -m .
s m mg , gz z m m in.
f mg m m mg.emg g mg, , gz
gh m in . ogz ,
mg .a m mg : g gh mg in , , , g,
z, m g in; z m in; fz mg m, m -m in; fz h mg z in, f z gm
m , m ; z m mg
in;
m g , g m, g ,m z m m j, f x m ;
gzz m m f, z f ;
z in, m fm cs in; gzz m in; zz m m f zf
z; cMp, m z m;
m g m ; gzz g f z m; gzz m g gh in; fz z z in , m
, f , m m z ; fz mkg zf, j g,
z ; fz m z mg z m
mz gm m m mg f;
d mg, m, f z mg :
7/22/2019 3514-Ghid Inv Phh
24/252
22 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
Dediagnosticepidemiologic,careinclude- m g mg;
- fm m f in;
-f z mg mg (gmg) mx m m in;
- g mg z in;- mg f f
;
-m g f;
- , f m g g;
-z mg z g g ;
-z m m f fm;
- fm z mg z fm cs gh in;
-f m m m in;-m m z g z .
Organizatoric gz mm mx m x f
;
z m x f ;
gzz f f m m ;
z g g;
fmz m-f m gh in;
gzz x f ; z m m x f
;
gzz mm hg in.
Metodic- m m x in,
m ;
- m x in;
-
mm mj m m x in;-fz, m , z z m g;
-g m f mg x in.
Decontrol
-fz m gm m ;
-fz xz m in, g z in;
-z m g z cs;
-fz m m , z g in;-fz m g g, z
, .;
7/22/2019 3514-Ghid Inv Phh
25/252
23
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
-fz gh mg m g- .
p m in m mg z z - (g mg) m , g f . r-z m x , m mg .
u mg g fm , , mg. rz g mg h gm m f z m in, f , -m, mg mg z m, .
a gz mg m g fm m m gm m, gz m
in, m , gz zf z ., f m in, z m m z, g m gm m .
r m f z m in m mg m g j m mg.s j m mg zz m g gh , m m mh, z f- m gm m.
7/22/2019 3514-Ghid Inv Phh
26/252
7/22/2019 3514-Ghid Inv Phh
27/252
25
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
capitolul 2.EPIDEMIOLOGIA INFECIILOR NOSOCOMIALE
2.1 Denie de caz standard de infecie nosocomial
Infecienosocomial (f ) - m () f, fz z z m, m f fz m - m gf, f mm mmg, x, m .
Meniuni:1. cz f m , m
m, z mz .
2. cz mf f z , mgm z, x z m , m.
3. z f , , z mf 72 gm mm, f .
4. z , f m m 72 , x gm m , z f m.
5. if m z g g fm mgm :
z ;
z zf; m g, z.
2.2 Particularitile etiologice ale infeciilor nosocomialei caracteristica lor
s g f m z m gmz gmg, , f- fm g. u m f g , m
z.ag g f m z g:i. Mgm g (Msp) m f
m , z f m g f.
ii. Mgm g (Mcp) z f m mm, z z.
7/22/2019 3514-Ghid Inv Phh
28/252
26 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
Infecii nosocomiale i agenii cauali mai frecvent iolai
I N F E C I I A G E N I C A U z A L I
I. Infecii respiratorii (fg, ,
m, , m ..)
s. , H. z, s. yg,
s. m, p. g, M. m
K. m, lg ., ..
2. Infecii ORL (, z, , g,g, g)
v, s. yg, s. ,
s. m, p .,
H. z, M. m, c. hh
3.Infecii oculare (j, k,f)
s. , H. z, s. yg,
s. m, p. g, chmy,h, , fg
4. Infecii ale sistemului digestiv (,, g, , ha, e ..) H b, c, d, G
e. , g e,cmy, sm , s. , s. f, c. fg, b. ,
v. hmy, Y. .. h a, e, , h b, c, d, G
5. Uroinfecii (gmf, f,, )
e. , p .,p. g, s. , s. hy, e. f, s. yg, b., c, um
6. Infecii ale sistemului nervos central(mg, f, )
n. mg, s. m, H. z, M. , l. myg,
s. , , h, fg
7. Infecii inamatorii purulente(f, , , gm,m ..)
s. yg, s. , s. m, e. , p.g,
8. Infecii genitale(gf, m, g )
n. gh, chmy, p .,
e. , s. , p, umym, Fm, h,thm g, G g,
M. hm
9. Infecii de plag i combustii shy, p, pm,b ., e
10. Infecii generaliate(m, m)
s. , s. yg, s. m,
p. g, e. f, e. ., c,
H. z, p .
11. Micobacterioe(m, xm)
M. m, M. k, M. fm,
M.
12. Micoe s g ag, M, pm
7/22/2019 3514-Ghid Inv Phh
29/252
27
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
s g f m g z m- , , m m m g m z f.
Mgm g, g f zm f g: x.
v g z x m m f- m m : z g , m m m -gm , g mgm , .. dz f m.
v g x z h gm h m m. M f g g. p m m g m m. dz f mm m.
Mj mgm g z f.
Mcp m f g . F h
m , gm gz, g .p mgm g x
m m, m x g, m,, , g m, mm z.
Mj gm m m z f (z).
Mm m gz mf m m g m h m Mcp. ex m g, m m m g mgm.
dz f m f mgm, gm m m m, mz f m, z m f g, hg - m mz, gm mm m ,z z mgm, m , z m f m f g.
d m, mgm g z m m f g , , z, g (K88, cFa/i, cFa/ii..), , gx, a, g z, - xx, zm g- (z, hz, z, mgz, ffz ..). m mg-
m g hm m f g mf g gm z z, mmm, mm, hg g m m.
ex gmg f g mgm g m z g z m m m .l x x , m f m x m f z .
pg f z g m mm g g mgm, j, zm f ,z f.
pzm g f m, g
, fm fm l m mgm, a g, fg, mm. M g g (m, , , m, hg,
7/22/2019 3514-Ghid Inv Phh
30/252
28 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
, hh ..) f g m f m- (mm g) g mgm. u mx g f f z m. F m z z, zzm, mg, mm, f.
ag g zz f m m f m g. u z f fm g (, m,mm, , , mg, m, , f, j, f g, .). t g fm g: m,mg, f .. z mgm g.
t m m m-zg g f g g; xm f z m, e. , e ., -, k, f , g g.
a f z f mx; m f -h m h . if mx
gz z g m f, , f mj z s. , s. m, e. , p ., p. g, .
e f x mm, , mg g mj mgm g, z .
if m z fm z z oculuibacterian. a g z z f- f m g, f g , hg
g f, fz g h m m z z xg . x g z m
m x (x gmg, x-x x ..) z x m, mgm x zm , hm, g m , g g m m g m hx, z. smm f, h, h, z, g h . p -f.
p m mgm g h gm m g mf - .
v xm hg (m f m m m m m ) m m m . a hg xm mgm g - m m m m m mgm g.
Hg mgm g mf mj g, z , , zf, f f z, fg . a mgm m hg - g z m m z. hg g m m.
p mgm g m hg, ,
m m. a m m , hm m , m ( m m ).
7/22/2019 3514-Ghid Inv Phh
31/252
29
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
M m m m f z h m h; z m -m x.
cm m m m mf hm z, x
.v mgm g mf f-m g z f f m z m f m fm z gm m.
2.3 Epidemiologia infeciilor sanguin transmisibile
2.3.1 Infecia HIV/SIDAsm m hz (sida) z z f f m g
m, z z m f z, m mg.sida f g 1981 g
m m m m m K hmx sua.ag g sida m m (Hiv) 1983 l M-
g (F, i p) r G (sua, i n c). z m m: Hiv-1 Hiv-2. if Hiv-2 m m m m m g Hiv-1.
z, m f Hiv f m: sida f Hiv. p msida f, z z m f g, -m f , m.
sida m f m m - f m-. ag g f g , fm , g g m f - mf g m g.p Hiv, f z , adn- g, adn- m, mg adn- m z . a Hiv m f f.
ag g f Hiv, t-mf, Htlv-3. e mx, fm f, m 85220 m. x z mm g- x. , mm . p , f gm m z
, m , m m 18 25 k, z 18 25, x, g g m g, g41 g120, m fm 34, 52 68. f , m , g z , 40, 55 g160. F g-m m , zz g fHiv/sida. p Hiv m, , gg, f g f g.
l z g f Hiv f m m f z mg, . c f g m. dg mf cd4 t-h, g m m, z g g
m m. if Hiv fz , f cd4: m,mfg g m, m m , g .
7/22/2019 3514-Ghid Inv Phh
32/252
30 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
if Hiv sida mf . t zz -m , m, , Hiv f f , z f m f, , mgm g. d m m g f mgm g f g gg m.
Perioada de incubaie f Hiv ( f m mm ) 10 m m. axm 50% z, f, 24 m f, z -m f , z fm g gh. a z z 2 m, m m . t g f. d mz , , m , .
p stadiul limfoadenopatiei generalizate persistente (LGP).p mm mf m. e m mf 2 m m z, m 2 m m m, m h 2 m m. lmf- gz m f m mm f Hiv z.
s m m z m, m complexul asociat SIDA.p g.if z , , f m. s m g, 3 m m, m m 3839, f , z m, m, m m , 10% g m m. g, , m mf,m t-h/t-.
Stadiul de SIDA propriu-zis m f Hiv z z- -m m f sida- sida-, f fm f m g. d m f ( mm 170 mgm g) sida- f 13 zg, g f f (. 1).
if sida zz - g, , z -m , m .
Tabelul 1. Clasicarea agenilor infecioi SIDA indicatori
Protooare Fungi Bacterii Virusuri
txm g
i
cym
pmy
c
cy fm
Hm m
c mm
sm
Mym m mx
Mym
H mx
cymg
hm
d m mg, m sida m K. sida m zz z , f m, mg,z gz, mz. sida z mfm , mm, .
Mz sida mz g fm f g g. f m f m m, g m fm sida mf m :
1. Pulmonar:m m, gz m, m ;2. Intestinal: z, g z, fg;
7/22/2019 3514-Ghid Inv Phh
33/252
31
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
3. Cerebral: (xmz), mg (), f (),m (mfm), m ;
4. Diseminat: m K, mz, z, f mg,xmz, hz;
5. Nedifereniat: f , g, z .
19901993, ogz M s c m sua f Hiv f z z m mm mf tcd4 g (. 2).
Tabelul 2. Clasicarea stadiilor infeciei HIV la adolesceni i aduli
Cantitatea (%)de limfociteCD4 n snge
Stadiul clinic
A
Asimptomatic,acut
(primar) sau AGP
BManifest
nici A nici C
CMaladiile
SIDA -indicatoare1 500(29%)
2. 200499 (1428%)
3.
7/22/2019 3514-Ghid Inv Phh
34/252
32 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
p f Hiv m. mz mg m f- f f z f h. v m fg, , z .
r f, f m g f. l f m g (udi), , x , -
x z, g .Evoluia procesului epidemic.- , f Hiv f m, m z . pm f Hiv/sida z m m, m. cfm pgm onu/sida, m Hiv/sida 40,3 m, 38 m ( 17,5 m fm) 2,3 m . nm 2005 f 4,9 m f, 4,2 m - 700 m - 15. d m sida 25 m m, 3,1 m 2003. pm m fm f Hiv/sida.
r M f Hiv/sida m , 2007 f g 731 z f Hiv (7,41 100000 ),
2006 681 (14,72 100000 ). 19872008 f 4145 f, 1192 z e . m f ,
. c m f - g m b (685,6 100000 ) mg: G (105,34), F (58,26), sg (66,28). s- -z m c (66,31), d (66,31), rz (44,94) ..
g n f f g . t(325,66) r (339,59).
d . 2000 f f udi, m x m. af, . 2001 udi 77 % m f , - f x 20 %, 2007 udi 30,37 %, m x 68,67 %.
m m fm f 26,72% 2001 41,58 % 2007. . 2002, xm 4586 g z gh -mg m b ch, f g g Hiv f. 2003, 10863 g f g 12 fm z. d 2003 fmm g, fz : jm . rz m fm f: 2004 m f 52, 2005 71, 2006 84,2007 81. c fm mg f m f mm z. 20012007
g f Hiv f 42 .c , f Hiv fz . p f 1524 20012007 26,3 - 24,26 % m f.
c , Hiv f gz . 20012007 sida-z f g 528 f. c m z f z, Mym z, z g g, m. a sida 155 .
mg m f Hiv/sida, z- f z, f m -. cm m sida m
m.M m m sida
g gm . p m f z gm
7/22/2019 3514-Ghid Inv Phh
35/252
33
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
19952000 20012005. z zz m -z pgm n x f Hiv/sida f -m x 20062010, H G r M . 948 05.09.2005. pgm f z z m mg z gm . e m m , m m , g , x f mm f, m f, m gmz m, g , g fz g m .
2007 f f g, pm lg c xf Hiv/sida.
dg f Hiv zz -Hiv. l 90-95% f -Hiv m 3 f, 5-9%- 6 , 0,5-1% - m z. c m m 2 m f. l m sida f z, m.p mm f g g m
f g g, , j f, m. a m , m hmfz. m sida z , m.
p g z - m mj z mh -g z g f f (g. 1).
Fig. 1. Marcherii serologici ai HIV la diferite stadii ale infeciei
1 2 3 5
Incu-baie
Infeciarecent Perioada asimptimatic
Manifestriclinice
ViremiaHIV
Seroconversia complet Viremia HIV
a-Hiv igG
a-Hiv igM
ag Hiv
a-Hiv igGc ag Hiv
if Hiv
Sptmni Luni Ani
7/22/2019 3514-Ghid Inv Phh
36/252
34 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
l f, f g, mh g fHiv z g Hiv igM. m- z , z igG, g . m g g .
M g z g z mzm aiF,
elisa eia (ezym lk im ay). r M g f Hiv fz - z g, hm m, g m m. fz 14 f ,mj m . t m -fm, mxm m- .l gz fz g (4).
f m m oMs/unaids, m j f Hiv , f f g f Hiv.
Prima strategie zz g . p g xmz
g , z mzm fz . M z- g () z mh Hiv. M z z() mh Hiv. u z g z.
Strategia a doua zz gh mg, , f- g gh mg , z m g . z m g z m mzm.M z g () z mh Hiv. M z z () g - , , , mzm , m z . a , , g f, m
m. d z z, m z mh Hiv. l z g, f m g, m z mh Hiv z , f z m. l z g z xm.
Strategia a treia zz g f Hiv. agm g z . 4.
dg f Hiv mj z zz g -Hiv1 -Hiv2, , m, -Hiv1, -Hiv2 -g Hiv1. z ( 1,5-3 , z .) g zz g m-g z Hiv. g- m g zz g mg m.
c g zz : m - de screening - deconrmare. l g m g zm -Hiv. ig m z g, , m, m z z, g.
l g zz elisa m m -Hiv1 -Hiv2, , z m - m -Hiv1,-Hiv2 g Hiv1.
M g g mzm . l z g, f z m - -Hiv. p m z g mh Hiv. l
7/22/2019 3514-Ghid Inv Phh
37/252
35
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
z g m g , f, , elisa . c m f m . l z z, m g z z mh Hiv elisa. l z g - , z m z (). M g z . r
, f z z m g (z, g,, ).
Tabelul 4. Algoritmul testrii sngelui la marcherii serologici ai HIV n diagnosticulindividual al infeciei HIV/SIDA
Prima proba de snge
Negativ:Se face concluzia privind
lipsa marcherilor HIV
Prima investigaie ELISA
Pozitiv:Mostra se cerceteaz
a doua oar
A doua investigaie ELISA
Negativ:Mostra se testeaz
a treia oar
Pozitiv:Mostra se apreciaz ca
coninnd marcherii HIV.Se testeaz a II prob de
snge
Negativ:Se face concluzia
privind lipsamarcherilor HIV
Pozitiv:Mostra se apreciaz
ca coninnd marcheriai HIV. Se testeaz a II
prob de snge
A doua prob de snge
Negativ:De a eclude greelile.
La necesitate a investigaa III prob de snge
Testare ELISA
Pozitiv:Persoana se evalueaz capozitiv n ELISA, proba
se cerceteaz n testul deconrmare
7/22/2019 3514-Ghid Inv Phh
38/252
36 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
p x g, - m m g, m- , m m ., m g mzm.
z m g, m , z z, g m.
d - f z g, mjz m g g m, zz - .
M z elisa xmz m. z z z f z f Hiv.
t g , m, fz g f sida c n -p M p, csida. cz f Hiv sida m gh m mg.
2.3.2 Epidemiologia hepatitelor virale nosocomialeAcualiaea
H (Hv) m g .u m z Hv m m mm g m. sg Hv iMs m: f mxm fz-, g m , m m-m j m g m ,
, m.r m m f x Hiv, Hvb Hvc
0,3%, 10-35% 2,7% 1.
Epidemiologia hepatitelor virale n plan global
H m m m m m-. c f z m mg m XX m m m fh m mj . d h z m, h z, m g g / m, m gm oMs -
h a b, h c m g , m m z h.cfm m ogz M s (oMs) 2 m g
f h b (vHb), 350-400 m f , f h d (vHd) z f . c 170 m f h c m m 10 m h d (vHd). , f gg, 100 m z h fm, 400 m h (Hc), 700 m z h (cH) xm 300 m z m h m (cpH). af m h b (Hvb)m 500 m 1,2 m , z 9- z m 2- z m .
1 c cmm d r. vm: 27s3, sm 2001, isbn 1188-4169, Hh c. a : www.h-.g./h-g
7/22/2019 3514-Ghid Inv Phh
39/252
37
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
p f vHb g z f z3 z m. a 45% m g endemicitate nalt Hvb (f mh vHb (agHb) jg 8%, f 60% x mj m ): afsh, a s-e, bz amz.
a 43% g endemicitate medie (f ag Hb z j 2-7%, f 20-60% g : oMj, am s c, a c, e s-e.
r (12 %) endemicitate redus (f ag Hb 2%, f jg 20%: am n, e n-v, a, am s, c.
r M, m, z m , j agHb 8%.
d mg oMs z m, infeciaviralCfz 3% . d gg zz 4 : f j ag, s; j (0,2-1%) e-
, am n, a; m (1,1-5%) e, zM, a, eg. e z xm 5 m m f h c. sua z xm 3,5 m f h c, g- 150.000 z .
v h d gg g, m z gg m (z M M, e e, rm, am-z z af).
r z f h b - 15-20%, c - 85%.
Epidemiologia hepatitelor virale B, C, D n Republica Moldova
p m fm zg , h b (Hvb) g 1966 34,3 z 100.000 .
m m , g 1974 mxm 85,5 /. u 47,9 / 1979, mz fz , 76,6 / 1987. 1988 mz fz m, z, 2007 6,67 / (g.1).
Fig. 1. Dinamica morbiditii prin hepatita viral B n Republica Moldova, anii 1981-2007
v m 17 , m mm- m , f g g,
7/22/2019 3514-Ghid Inv Phh
40/252
38 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
m g h b d, 14 . af , Hvb m m 14 - 1002 z 1989 17 z 2007 60 .
a m hm m m 15 m m . d -
m m , m m . g (15 m m ) m - 1836
z 1989 222 z 2007 (17 m m ) 8 . a , m x (), m -x , .
a m , g m f f , m m , m m g f vHb g f.
z , m Hvb, m g
mj ( 0,2 100 m lxmg 1,8 o) m h , z h mh. i m h z h 772,9 1989 1693,7 2005.
Morbiditatea prin HVB acut n Republica Moldova dup vrst i sex.
u f g m f f x , m g . p m Hvb f j m, gm mm Hvb m 1994. z, g 0-2
3-6 13 (1995-2007) z 238 z . p xm m m m Hvb, 55,8% 44,2% x fm.
Hepatita Viral C
p 1989 h c (Hvc) h nanb mm f. az h c, g m f, x g , f h c.
H c, g rM 1991.
d z g 2 mz f m f 1996 1,62 / 7,6 0/, 4,7 . ,
1997, , g 2007 2,9/. z Hvc g 20-50 .
az m Hvc fm f g g m x m 52,7% 47,3% fm,- f m. a, m Hvc m m, , , m, - m m Hvb Hvd.
Hepatita viral D
p mg h d m m m f vHb, f g g h d f -
7/22/2019 3514-Ghid Inv Phh
41/252
39
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
f f m z h b M h d (Hvd) gz 1991. p , mm 0,14/ 1991 1,9/ 1997, m 0,6
/ 2007.
Fig. 2. Dinamica morbiditii prin HVC i HVD acute n Republica Moldova, anii 1991-2007
p g m Hvd . c x m f f f, Hvd f f h b c,
m m, 66,3%, 33,7% fm.
Perioada de incubaie
a) Hepatita Viral Bp m - f vHb z 45
180 z. m m Hvb 30-90 z m-m f. a .
b) Hepatita viral C Hvc, fm mj , z 14 110
z, m 28-43 z. dg mz, gm x m m g vHc.
c) Hepatita viral Dp Hvd z 21 90 z, , g, .
receptivitatea populaiei
a) Hepatita Viral Bs f vHb f
h b fm , , mmk h b: agHb, -Hb / -Hb. iz Hb-gm j
f, -Hb z m. p -Hb Hvb ; , z f vHb .
7/22/2019 3514-Ghid Inv Phh
42/252
40 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
b) Hepatita viral Cs f vHc Hvc
fm , , -Hvc g.c) Hepatita viral Dp z Hb-gm.
p f vHb vHd h d / b fm . p f vHb vHd - h b, Hb-gm.
Sursa de infecie
a) Hepatita viral Bd f v H b f fm h b
, g f vHb (agHb), - Hb-gm mmm 6 . u f z agHb m g z g vHb
(agHb). p f g 2-8 m m h b, f z f mm m h, x. F , z g, g, m g. m m mg m z udi. b- h b agHb m mg f g . G agHb z z f .
b) Hepatita viral Cd f h c (vHc) f fm h
c , vHc, z-Hcv g. d z m m, m f vHc -
f, , z z, h c, Hvc (fm ) Hvc, z m f.
a f m m m-g Hvc, m m f z -Hcv z, arnz alt . G -Hcv z z f -. b Hvc m mg f g .
c) Hepatita viral Ds f z Hvd vHd,
agHb -Hdv g m-mm 6 .
Mecanismul i cile de transmitere
a) Hepatita Viral Bl h b agHb mediilezio-
logicealeorganismului (z mm ). c m f, f Hvb, 0,00004 m, m m g m xm 0,0001 m 100 z f h b.
rz m h b, g x vHb , m-m f f . nmz g m mg
7/22/2019 3514-Ghid Inv Phh
43/252
1
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
m x m f Hvb.
Cile naturale Perinatal ().: m mm f f m ()
( z ).
Orizontal: m z h f m . Seual: m z x f.
Cile articiale Nosocomial m f m
m mj z f m .
Pacient-medic: if m f. Pacient-pacient: if f m
hm m m m m m
m- (manipulaiistomatologice,operaiichirurgicale,hemodializ,transfuziidesngesauderivatesanguine,transplantdeorgane,injecii,colectareaprobelordesngesaualtemediiziologicepentruinvestigaiidelaborator,cercetriinstrumentaleendoscopiceetc.)
Medic-pacient: f g m f. Pacient-societate: if z f m
m m m z , , fm .
Habitual-comunal m g g m h m m m m ( g: , , , mh h,
z m m .)
Caracterizarea cilor naturale de transmitere a virusului hepatitei B
Transmiterea perinataltm vHb mm f m m
m h b m - z f mxm. d fmz z f , , , f m.
p m transmitereperinatal g f g (), f , zz m . axm 98%
z f , 2% - fz g. d- agHb g cz.tm z:1. c fm m Hvb m g, m m;
2. c fm Hb ( agHb).
v m f mg.e h f z hm g 3.
7/22/2019 3514-Ghid Inv Phh
44/252
42 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
Figura 3. Evoluia i sechelele infectrii perinatale cu virusul Hepatitei B
im m vHb z m f agHb g- agHb.l f f f ( gj ) z.
Transmiterea orizontalu m z Hvb j agHb g m g- g - m z. g, z m g zg f.
tm z m f m .d m, z z . f f
m h fm agHb.Transmiterea sexualr x Hvb m. tm
z m m m, g g m-
fm , h b. a f m -m hm hx vHb x m, x agHb f b sx tm (bst). F : m hmx, g-, m f m.
Caracterizarea cilor articiale de transmitere a virusului hepatitei B
Transmiterea pacient-medicr m m . p f
vHb m z hm m x f g m m m , f x. c m , 25-30%, f - m hg m . p mm
Mama cu HBs - antigenemie
AgHBe pozitiv
Frecvena infectriiperinatale cu VHB 70-90%
Portajul cronic al VHBse dezvolt la 90%
nou-nscui
AgHBe negativ
Frecvena infectriiperinatale cu VHB 10-30%
Portajul cronic al VHBse dezvolt la 10-15%
nou-nscui
7/22/2019 3514-Ghid Inv Phh
45/252
43
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
f vHb f (5-6%). c m f zz m j, g, g ( f), g zf m.
Transmitere pacient-pacientr f m- m m m
m m r M, f h b (vHb) g 8%. if m hmz, fz g , g, m m m- m m , g, gz, , , , m .
Transmiterea medic-pacient m m (mg, gg, hg, .) - g z
m vHb m f . im m m- m m m z m f z m m mm .
z f m agHb agHb z m m ( 41) f g .
Transmiterea pacient-societate f m m f m m m m g zg gm, m z x m, f f mz z m -, m x f m.
im mg m m vHb M : i g m m m
f;
n , , m
gh gm -mg m- , ;
sm j;
tm g ;
p z m.
Calea de transmitere habitual-comunal z f m g mm fm, m , , zm ., zf z m m m z m (fz, mg .).
Factorii de risc asociai cu transmiterea VHB
) H b tfz agHb z; M m ; n mm f vHb; am g; Hmz; am m mm j; c x / h z agHb z;
p x m; exm m m, z m.
7/22/2019 3514-Ghid Inv Phh
46/252
ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
b) Hepatita C tfz f; am g; Hmz; tm f m m m; c x / h z -Hcv z; p x m; n mm f vHc.
Controlul infeciilor cu virusuri hepatice B, C i D
v - g h b d;
sg z agHb -Hcv g, g, m ; r mxm fz gm g j;
t m agHb Hvb; ag z m m
m f; m m f m f; ogz , m, h
f m m z; e g mm x f
g ; ag , m, h m m; tm h .
PersoaneleAgHBsianti-HCVpozitivetrebuie:
s f;
s j z ;
s fm m x;
s fm m , g z;
s fm .
p m agHb -Hcv z m m.
PersoaneleAgHBsianti-HCVpozitivenutrebuie:
s z g, g, m;
s m mm m h f g ( , , , mh h, z m m .);
Prolaxia hepatitelor virale
o m m, g f,
gm, m x .
7/22/2019 3514-Ghid Inv Phh
47/252
45
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
Prolaxia specic a HVB i HVD
c m m h b mm .p Hvb :- v Hvb m mm m m z
h , z h m h.
- v Hvb m Hvd.
- Mj z z mg .px Hvb zz m: mz .Imunizarea activ m Hvb.v Hvb f m z : - -
m m g.p x f mg Hvb (HbiG).Vaccinurile derivat plasmatice (VDP) agHb, m
agHb z agHb ( , fm / m), - hx m. a
f, m -Hb(). uz m mm, hmz g.
Vaccinurile recombinant genetice: g g agHb j (shmy ). a gz agHb, hx m hm. thg g f m g gz.
Imunoglobulina specic contra HVB (IGHB) m m, z -Hb (m m 100.000 ui/m). am iGHb m mz -Hb m z x. iGHb m m 48
x vHb, m m z . p m z m3-6 . um z m x(hm x).
Vaccinuri combinate
v Hvb m cm-G (bcG), j, m (ror), Hmh z (H), hh, m (dtp-).
pm z Hvb m g m. v- m f z .
dz 10 mg, 20 mg agHb.t m m 2-8c. cg -
g g j, f mg.
am 95% .s m , m z ( > 40 ),
mm, z fm.d f mg m f : f g, hmz, Hiv,
( f, g -, hm ).
p Hvb x : f > 38,5c, h- m , m m z .ef : , g j .
7/22/2019 3514-Ghid Inv Phh
48/252
ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
Dozajul i schemele recomandate pentru prolaxia de pre-expunere cu vaccinuri contraHVB
v Hvb m m g mh g m. p m- m dtp, , bcG j. M m , m
.d m Hvb mz z (mm) f f m -Hvb.
v m Hvb mz , f.l mm f hm Hvb m 0, 2, 4 , 0, 2, 6
, 0, 1, 5, 6 , 6, 10, 14 m, 0, 1, 2, 12 0, 1, 6 , hm rM.
p f hm 3 , mmm - x f hm 4.
d -Hb 10 mui/m f f m mj a, m f agHb.
z m 3 z m m 10 mui/m m m z m .
z hm f m , m m .
r m z m m m m g .
l mm x f m
m g.
Prolaxia post-expunere
z x f vHb, mz g img Hvb (iGHb).
Prolaxia nespecic a hepatitelor virale B, C i D
px f z x g mx m m m, h.
s x m m g g h b, c d f m, , g m m.
rz :1. t z agHb -Hcv g m, m, ,
, g;
2. r mxm z g;
3. imm fz g;
4. r mxmm m g j gm;
5. c, mj h x j zg m hm m , m ;
7/22/2019 3514-Ghid Inv Phh
49/252
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
6. d agHb, h mm fm f m h m m ;
7. c , hm g f f b, c, d: udi, f m , h, z, , g,
hm, Hiv/sida .8. ag h , , m, m, m hm z m z;
9. ag m hm , f;
10. tf m agHb z, z agHb , f z, m, f m .
m (fz, m, mh, h, ),x f g j -z g m z.
h, x f f - , z m.
testarea donatorilor de snge i grefe
t g g g agHb m- mzm g mm agHb 0,025- 0,1g/m. s m z g fm ( m )
z M s.s m f m m , z m mm. p -m m m pcr.
Testarea donatorilor de snge i grefe la anti-HCV
p h -Hcv m - agHb. r z 2 g Hcv (ns3 ns4).p m z z, m m.
af 1997 G rM m H .507 pgm
n m h b, c d. a pgm mm x . af - - Hvb g m m m, fm h , hmz, mfzg ..
d m f mm z g m m f, g z agHb -Hcv -m - , m m j, mz zm m f . z - m Hvb,Hvd Hvc m f m m . d m m g m g mj . m f G r M h .
1143 19 m 2007 pgm n m h b, c d 2007-2011. chz z gz x - pgm m m, g
7/22/2019 3514-Ghid Inv Phh
50/252
48 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
m , gz h , j h, , .
d x m mj z. o m m m f m.
2.4 Infeciile septico-purulente
2.4.1 Infecia chirurgical f hg f m: f
hg, f hg g, f -, f . o m f hg m f zz m f g- hg (35).
Frecvena infeciilor chirurgicalen m hg m m, f g
hg m g (9, 10, 15, 21, 31, 38).if hg m f g m.
sua, xm, f hg f m 24,0%. m 40% g m m 80% hg (11,35).
u f m m. ch, 1996-2002, f, 1301z ispn g , 66,3% hg (19, 21).
cfm hg m inspz f 5,0% 35% m (1, 7, 8, 12, 20, 22, 31, 32,33, 34, 36, 38).
F f hg m m , , g , m , g , z m.
u oMs f m m o mj a s-e (11,8% 10,0%, z), g g o (7,7 9,0%, z) (17).
sua f f hg 0,5 25,0% m , . M 9,8%, sk-pg 9,0% (35).
u f f hg m f f .. (2002),
gh 45327 hg, 20 (1980-2001) 4002 z f - m. z - f m m g 88,31,65 1000 , m f m - m m 230,8610,78 1000 .
a z m, , m hg- . ch. s- hg m f - hg 83,16 1000 8,31%0,87 ,
mg , , 74,2 7,42%1,05 (23). s- , 45,0% m g m (23, 27).
hg, xm, f z 1,8% 22,2% f
(24, 29).i f hg f hg. u f (23) m hg g m
7/22/2019 3514-Ghid Inv Phh
51/252
9
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
f hg z hg (416,66). d zg m - 224,5, hm 133,3, -m 116,2, m 83,76, hm 55,71, m 183,3, hg 58,8.
l mg m - z f z-
m-g m m f , 80,43% m . i f m -- m 130,28. m f ispn
mm 142,85. m, , m f f hg g
hg g (571,4), m x j (333,3), (157,9), -z (120,4).
if m fm mg g f m m m f. t, m g m f m f (21,22, 23).
u f (25, 26) m, mg m /m, hg g g , hg mxf gm. cfm (38) m m f gz m,
g f m , gg m.u m m mm f f a. ph (2006), -
hg m m hg m g hg (45,8%) g hg f (19,9%). d fm mf f hg f : j (10,97%), - m (7,32%), f (3,66%), (2,44%), hmm (2,44%), m g (1,22%), (1,2%).
if m z . r f hg 2% sua g 7 z , 10 z s. pg (35).
z f c r. (4) - 8 z f g 3,3 z gg 9,9 z hg g, 19,8 z hg .
z f m m ch (23) - zf hg g 11-14 z.
pg z in m m mj h m (14, 28). Mj h m g g in m m m . d xm-
M W.J. . (1992) sua m, m z in g 7,3 z, h m 3152 (t.G. em ., 1993), g m 5 10 m .
Criteriile de determinare a infeciei chirurgicale nosocomiale
i f hg g , mg m (), . d z j h m, g in. z m in m.
sm gh f m sua
m f hg.cfm f hg m 2 g: f g f -g/.
7/22/2019 3514-Ghid Inv Phh
52/252
50 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
if hg z m g, f, -m m m , f f,
m m f.if hg g m m gm
(g ), x gm g z, f
h f m (35).
Deniii de caz n infeciile chirurgicale*
Infeciachirurgicaldeplagsupercialif m z 30 z g m
g z. l m:1. s z, f m , f m
m.
2. iz mgm h , m z g f.
3. Mf m m mm f: z (), m m (m), hm(), f f g( z z z), z, z m , f z, h g hg.
4. dg f hg g m hg m.
Infeciachirurgicaldeplagprofundif m z 30 z m, m z
z z m ( , , m , z ) m , f g , f m f ( xm f m) g -z, m:
1. s m z, g .
2. dg g h hg, z m m mm f: f (>38c), z , h z z g g.
3. l xm , m , xm hg mg m f z z f.
4. dg f hg f hg m . M:1. if z f, f, gz f hg f. 2. if g/, z, gz f hg f.
Infeciachirurgicalaorganului/cavitiiif m z 30 z m, m z
z m , m f g , f m gm (g ), xz z, f h m m , m:
___________________* l z z f hg f cdc pgm
nnis sua (35)
7/22/2019 3514-Ghid Inv Phh
53/252
51
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
1. em j g . M: 1. n f hg g/ m z j g (), f m f fzm.
2. d mgm h , m g f.
3. l xm m , xm hg g, m f g .
4. dg f hg g/ hg m .
o zz insp mzm g, g . l gz 140-150 mf isp, fz -m f gm.
cfm (19) f m m ch z z ing ( 1996-2002), f - m - mf 70 . c m insp f g hg, 45,8% fm g g. a f m g: g , m g, g , , z.
if g hg f - 19,9%, 29 fm g: , , fgm, m, h-, , , , z, zm, m, g, gm , gm ,gm , gm m, , ,mm , hmm , hmm g, , - f, hmm , z, z .
if m 2,53%. d f fm m, m , m j , mm m-, , m f.
if 12,06%, g: m,mm, m, hm, m, , , g , .
if m 13,29% fm g m mj z g m.
if f 3,97% g g xg m m hm m.
if m - m 0,92% z, g
x, m, , .if m - m 0,76% z z m-
g .if h, h z m 0,76% g -
hg, , fm, , g .
Particularitile etiologice n infeciile chirurgicale nosocomiale
s f ispn z g mf , g.
ex (20, 24) mz fm. d 132 m-gm z m - hgm 29,5% z e. , 12,9% - s. m, 9,8% - s. , 9,8% - p. g, 8,3%
7/22/2019 3514-Ghid Inv Phh
54/252
52 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
- K. m, 6,8% - s. f, 4,5% - p. m, 3,8% - s. m, 1,5% - a ., 13,1% mgm.
u (27) f mg 138 m, 40% m, m mzm g f g.d 131 z 36,64% s. , 20,68% - s. m, 10,69% - p. g,
8,40% - e. , 7,63% - p. m, 3,82% - p. g, 3,05% s. yg c ., 2,29% - e . e. f, 1,53% - mgm. sua f hg - m .
fm m nnis (3) (. 1990-1996; n=17671) m f f hg z s. (20 %) gzg (14%), e . (12 %), e. (8 %), p. g (8%), e . (7%), p. m (3%),K.m (3%), (3%), c. (2%), mgm gmz (2%), b fg (2%). u z f m f h m-gm , m rhz yz, cm fg, rh h-, n f, lg mh, lg mf pm m.
a, g z f - m
mj mgm -z , g, m .d mj , mgm
z m x. t hzz z f z . am z m x z hm- fm , m , h hm zf.
m m, mj mgm, , m. t, m, z -gm z, g g, .
Patogeneza infeciei chirurgicale
if ( f) z mgm gz m-gm m mgm, f m- g m gm.
cfm c p.J. (1992) z f hg z m f:
Dozamicrobiandecontaminare
Rezistenaorganismuluipacientului=Risculdezvoltriiinfecieichirurgicale
a, z f hg z m m m gm.exm - , z f g
m mgm - gm 105-106 m.c m m zm z , f g oMs-
42 14 , m f : 13% - , 16% - , 29% - m (11, 35).
exm, m , - g z m - f hg 102-105 gm (35), f m gm.
c , f if i (22), m fm.
u mg f m m , 1-2 z hg, hm mg- . dm igM f g 58,5% - 64,0% ; igG - 39,6%-44,0%
7/22/2019 3514-Ghid Inv Phh
55/252
53
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
iga - 32,0% - 42,9% (p>0,05). nm fg f 2 mz, f m (58,53,0%) 29,61,4%.
t, , m , , - m --, f 2 m m (56,0%) z , m f m (27,9%) (p
7/22/2019 3514-Ghid Inv Phh
56/252
54 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
e m f z g mgm -gm z f . a, m g h g.
u m z g hg, h, f m-, , z z g f hg,
h m. c g z m , h, m m ( ).
Factorii de risc
p g f g, f m z f z fm.
cfm oMs- f m m in g : g m m, mj m hg z, m f, mgm z , m in (oMs).
cfm f sua (35) f z z fhg m:
Factoriasociaicupacientul v
am
d
Fm
oz
if m z
cz mgm im m,
d z
o
Factoriiasociaicupracticachirurgical th hg
i hmz
o m
tmz x
c m hg
Hx
Hm
b
pg m
d
v
sz m
pz z hg
dj hg
G m g
7/22/2019 3514-Ghid Inv Phh
57/252
55
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
r m g m f f m.
s- , f m m m m m, m (A.. ., 2003; v. p, e. r, 2008).
hmg in z m, m f -m g m.u mg f (19) insp f
m m f , m gm, (60 m ),g z, z g m, m (g), f -m, hg , m f ( 8.00-18.00), z m-g m, m. d xm,- , m - f m 3 m
g m (z, f , f g) m f g m (20,292,82% 6,190,64%, ). rm ispn 4 m m m g m
m (16,782,18% 4,010,65%, ). d m hg hg g: z f m h-g 2,05 , m - 2,80 . f g hg : z m h 1,45 , ,2,25 , 1,36 1,64 , 1,50 2,23 , g 2,07 3,00 , z 2,09 4,20 , -1,58 2,08 , hz 2,09 2,2 ; mg hg f m f 1,13 , m - 1,52 , : f hm 1,0 2,45 , f- gm 1,22 1,39 , z 1,31 1,5 , mm 1,13 2,05 ,.
d m m 14,85 z fm 24,45 z m -, 11,36 25,43 z hg m 12,33 23,47 z m .
s- m f m z f hg - z 6,050,81% f m z 8,231,20%, fm z f hg - - z 26,323,74% .
sm m f m - -. cfm (29) f g g m , 7.30 24.00, m g . a (2) mz f g
f , 24.00 8.00.p (23), (n=1606), z f hg (ispn) m m f (8.00-12.00) m (12.00-18.00), f 8,080,92% , , 8,461,09%. l 18.00 24.00 f insp 3,942,23%. l ( 24.00 8.00)m - - f .
Bibliograe
1. bj a., ch a. omz m gh mg f-. omz gh mg . e, 2000, .
268-276.2. c M.a. H if c: p p. nw-Y, 1987, . 256-265.3. c f d c p. n nm if s
7/22/2019 3514-Ghid Inv Phh
58/252
56 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
(nnis) , mmy fm o 1986 a 1996, My 1996. a fm hn nm if s (nnis) sm. am. J. if c, 1996, 24, . 380-388.
4. c r. . th f f g . JaMa, 1994, 271, . 1598-1601.5. c p.J. sg w f. i: Wwz M.J., . if d. phh:
1975; 130: 579-84.
6. c p.J. sg w f. i: Wwz M.J., if d. phh: W.b.s c, 1992, . 558-564.7. d p., v., ph a. u mg m -
m hg m. ch. M. cg. v ig, em-g Mg r. M. ch, 2003, . 2b, . 142-144.
8. i M., M-d l., c d. . sg f h sgy c f hH c Kgj. M. pg. 57(5-8), 2004, . 369-373.
9. i a. if m: , z . bg, g, zg,mg. 1994, . 39, n 3-4, . 161-167
10. Jg Z., a c., M p. . nm f g m. p-g. bg. 1991, n 5, . 561-564.
11. Hy r.W. . th w m f . a w f . am.J. emgy, 121, 1985, . 159-167.12. Km-Hm t., bk H., t a. . s f h q f
g w dh y h. if c H. em. 24(8), 2003, . 584-590.13. Kh n.n. . cm f w hg f my. M m
. Khg (Mk), 1991, . 119-123.14. Kk K.b. . th m f g f h 1990: my,
x gh f hz x . if. c. H. em., 1999, 20, . 725-730.15. M M. e q s f m. b lam
M. 1993, n 5, . 719-726.16. M W.J. . i f m m m f. i:
b J.v., bhm p.s., . H if. 3 . b: l, bw c, 1992, . 577-596.
17. My-Wh K.t. . a y f h f h-q f.J. H. if., 1988, 11 (sm a), . 43-48.
18. ph a. emg f - m m( m m. ch). tz m. ch, 2006.
19. ph a., p v. a mg f - m m m ch. a usMF n tm. ch, 2003, .1, . 337-342.
20. p t., p v. u mg f - m.
a usMF n tm. v. 2. ch, 2001, . 211-215.21. p v. pm f m. c m, 2005, n 3, . 47-52.22. p v., b s., p t. r f f m
. sgh mg m r M. ch,2000, . 29-32.
23. p v., ph a., Jh c. e mg f f- m. b aM. m. 2005, n 2, . 73-86.
24. p v., p t. s g f m - hgm. M. cf. usMF n tm. ch,1998, . 180.
24.p v., r e. p mg f hg. b a-
m m. 2008, n 2(16), . 13-22.25. p v., s v. c mg f - -
. Xv-m s j m . 1999, . 42-43.
7/22/2019 3514-Ghid Inv Phh
59/252
57
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
26. p v., s v., p t. if mg. M. cf. . usMF n tm. ch, 1999, . 195.
27. p v., s s. p mg g m.b aM. m, 2006, n 3(7), . 261-270.
28. Wk d.s. . c f m f: f y, -
, m shy f. am. J. if. c, 1988, 16, .185-192.29. Wenzel V.P. . ., 1990.
30. ..
- . . ., 2002, . 9-13.
31. .., ..
. , ,
, . ., 1999, . 116-117.
32. .., .. . ., 1993, 228 .
33. ..
.
, , , . ., 1999, . 119.34. .., ..
. . ,
, , . ., 1999, . 124-125.
35. . .
. . ., 2- . ., 2003, - 478.
36. ..
. , ,
, . ., 1999, . 196-197.
37. .., .., .. .
. ., 2002, . 53-58.
38. .., .. . ., 1989, 168 .39. .. . . .
., 1999. . 62-67.
2.4.2 Infecia cilor respiratorii inferioarecfm nnis (sua) m m f m
f ( f hg g f ), 13% 18% in (8).
r M, fm g f m
f 3,97% g m x g m hm (2). csi, r M, x f -
m f z g z m f. t m m z m z h-g z, m m,m mg (8).
u (7) f m m m f f 9,7% (. 1999), g m g 42,6%.
t f r M m hg (p v., r e., 2008) f m - f 41,5%.
7/22/2019 3514-Ghid Inv Phh
60/252
58 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
.. . (2003) z in m m 76,3% g f m.
cfm .. , .. (1999), m m m: 10 1000 , hg 15 1000, z m 54 1000 . l m m -
m : 3 z 1000, hg 7 z 47 1000 . t.G. M . (1999) 14% -m m m hg g. v m 60 .
l g f m f m, ,h, h, h, m mzm m.
Criteriile de denire a infeciilor, cilor respiratorii inferioareA) Pneumoniile nosocomiale1. pz m xm m:
) , m ;
) mgm z >105 ;
) mgm z hm ;
) z mgm g h, ;
2. l xm g - z g, , h m:) mgm 104-105 gm/m m ;
) mgm z hm ;
) z mgm g 104 -105 h, ;
) z g ;
) g igM ( ) igG ( h );f) hg m.
p , z m m: , h,, whzg, gh, m j .
B) Bronita, traheobronita, traheita (fr semne sau simptome de pneumonie).c:1. m g m z m: f
(>38c), , , m:) mgm z h h (104 105 gm/m);
) z g m .p , f m g m: f (>38c), ,
, , m: ) mgm z m h h (10 4 105 gm/m);
) z g m ;
) (igM), igG h .
C) Alte infecii ale tractului respirator inferior (abces pulmonar, empiem) trebuie sndeplineasc unul din urmtoarele criterii (1, 2 sau 3):
1. mgm f, - z m h
m, h ;2. m mm m hg xm hg;
3. m, g.
7/22/2019 3514-Ghid Inv Phh
61/252
59
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
d g g m m g m f , f f f.
cfm c c sua z mm 5,9 z, h m m m m h m in, g mx m
(1).t, fm sua, m m 13-43%. r m m m (8). .. . (1999), , z m jm m m m.
Etiologia pneumoniilor nosocomiale
pm m m f , m mx, f () mgm mz m.
c m g fm m m m-gm gmg (pm g, e ., K m, eh-h , s m, a . .). cfm nnis mg-m m 60% m m (1).
cfm (9), g z m m z K. m 19%, (m ) 19%, p.g 15%, c, e, a 8%, F, e. 4%. m jm z f f mx.
l f , m m mf s m Hmhy z. pm -
m f , m f hg g . m fg, c -
.pm lg . ag g m f
z.pm m m f
g, m f .
Patogeneza pneumoniilor nosocomiale
Mgm m m m m f, m, fg g, xg.
ag z m f f m: m, mgm zz --fg m, h z m m . e mgm hmg f.
e f, z fg mgm gmg z m m . cz m mgm gmg g m , z g
fg g m, g, f, m-gm gmg m m.dz m m m .
7/22/2019 3514-Ghid Inv Phh
62/252
60 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
Factorii de risc
Factoriiderisc,dependenidestareaorganismuluigazd: ( - );
g z;
h ; g (z gh);
m gm;
f ;
m hm... , .. (1999) z m m -
h 72,1% m m.Factoriiderisc,dependenidemediulspitalicesc:
m;
z ;
m; zf j mj gj (z , g zg, f m zg , m zg z , m , f j m ).
Factorii,cenlesnescprocesuldeaspiraieamicroorganismelor m;
hm;
h ; f z- g;
m z z;
m;
h m ;
h m -.Factorii,cempiedicevacuareanormalasputei
hg , g, gm m;
;
f z; mz.
pm m 20,8-45,0% z m (3).
Bibliograa
1. c f d c p. n nm if s(nnis) , mmy fm o 1986 a 1996, My 1996. a fm hn nm if s (nnis) sm. am. J. if. c, 1996, 24, . 380-388.
2. ph a. emg f - m m( m m. ch). tz m. ch, 2006.
3. p v., r e. p mg f hg. b aM. m. 2008, n. 2, . 13-22.
7/22/2019 3514-Ghid Inv Phh
63/252
1
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
4. .. : .
.: , , ,
. ., 1999, . 83.
5. .., .., .. -
. .:
, . -,2003, . 73-75.
6. .. . . .:
, , , . ., 1999, . 155.
7. .. .
. . ., 2002, . 43-50.
8. . .
. . ., 2- . ., 2003, 478 .
9. .., .., ..
. .: , ,
, . ., 1999, .213.
2.4.3 Infeciile tractului urinarif (itu), fm , m f-
f m r, xm, - 22,0% (5), sua 40,0% (2) f m.
z f .. i .. (2003) . Km, - in m m 25,43,2 100 j z. M f f m f (75,010,8%). m
45,515,0%, gg 30,08,4%, hg g 33,310,2%, m 17,94,7% g 7,54,2%. um m x, x h m f m g.
Mm f m- z f m.
z hz f m z m 4,5 25 z, fm F r (9) 1,0 3,0 z, fm sua. t, h m g m g z fm m 3803$ (1, 9). r M m f f. l f - f , , fm - , m f z z m (9).
Manifestrile clinice principale ale ITU
f
g hg
Criteriile de diagnosticare (deniiile)
tm f , t - m m. b m m f
7/22/2019 3514-Ghid Inv Phh
64/252
62 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
z g , g, g, f mm, m f z mm m , z , h. 43,7% z f mf, 56,3% z mm (6).
d itu m, m .if m m m mg:
mgm 105
mgm/m, z mxm 2 mgm.
Criterii de denire
A)Infeciasimptomatic z z m m:1. F (>38c), h, , 105 /
m , z m m gm ( m f m, ,f h : g, m mjj, z );
2. d m m: f (>38c), h, ,
m:) ( 20 mm3 , >3 /m, >10, 40 (10x40);) z mgm , f m Gm;) z gm ( Gm g ) m 100 gm/m mgm;
) 104 - 105 gm/m g mgm ;) m;f) g m.
p z m m: f (>38c), hm (38c), , m:) j f;
) mgm z hm ;) g m g g , mgmz, z mg, xm z;
7/22/2019 3514-Ghid Inv Phh
65/252
63
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
) g m;
) m.p , z m: f (>38c), h-
m (
7/22/2019 3514-Ghid Inv Phh
66/252
ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
3. M m.4. cz m5. cz g. i itu f m. l
z m h, 10- z m, f z 50% z, (9). l 1000 z m 8 10 itu
(6).6. n gm () .7. t g .8. F m j h.9. t z. i itu z f m
1,9 m , z f (38,2 20,1 100 z, , (p
7/22/2019 3514-Ghid Inv Phh
67/252
65
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
8. .., .., .., ..
. . . .-.
. , 2006, . 63-68.
9. . .
. . ., 2- . ., 2003, . 167.10. .., .. . ., 1989, 168 .
2.4.4 Infecia nou-nscuilor i luzelorp m f m
m isp m.if g, z - m f m.
z (2, 3, 7) f m z 10,0-18,0 27,8-35,5% m - 6,0-9,9% z. f m m - m (17,5-21,3%), m m 2,7-3,5% z (5, 6, 11). t, F r, fm , f
f m - (. 2000) m 0,66% 6,6 1000 .cfm (6) m - z 34,9 72,5 1000, .
pg m - - z m m fmg.
Lanou-nscui: j m m
mf mg (), veziculita () fz m m , gm mg m m f j f
Laluze: f g m , z m m f j
m , , f f
7/22/2019 3514-Ghid Inv Phh
68/252
ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
d f g m g m - z. cfm m 5% fm z zf g. u m z f fz (10).
o m f m z, g,
, . r f m m z, : 5% z 85% g, m 1-3% (1).
Criterii de diagnosticare
Infeciadeplag (z mm 2.4.1).
Endometritaem m (1 2):) mgm z h m, , ;
) j m: f (>38c), m, .
Infeciaepiziotomiei. c (1 2):) j zm;
) zm.
Infeciapereteluivaginal. c (1 2):) j g;
) g;
) mgm g z h j g,
g.Alteinfeciialetractuluireproductivfeminin (g, , f, x
m f m g). c (1,2 3):) mgm z h f;
) fm mf f m hg xm hg;
) m: f (>38c), g, , , , m:) mgm z hm;
) g m.
Infeciapielii.) , , z, f;
) m z f: , , m, hm m: mgm z , f;
mgm z hm;
z g m f;
gg, m xm m f;
igM , igG, h .
Mastita.) mgm z, mm f h j z j, ;
7/22/2019 3514-Ghid Inv Phh
69/252
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
) mm f m hg, xm hg;
) f (>38c), m ;
) g m.
Omfalitanou-nscutului. c (1 2):1. em / j g m m:
) mgm z h j ;
) mgm z hm;
2. em j m.
Pustulozacopiluluisubunan. c (1 2):) z m g
) z m m
Infeciacircumcizeisugarului. c (1, 2 3):
1. dj mz;2. em, m, mz mgm z
z;
3. em, m, mz mgm z f ( mgm f m m, ) g m, m m m.
Factori de risc
Pentrunou-nscui
m, g m m 1500 gm mm f hz m m g g hg
Pentruluze m f m g h g z
s- fm g m m 3 m f, mm ; 2 m f f m f mm g ( g, h g, hmg, .) 4 m f z g . c m , x,h, m m j g m 7 m f f m g (7).
f m - m j, 26-30%. m 35,0-40,0%, mf 8-10%, m 5-7%, fm gz (m, m,mg) 4,0-5,0% (11). Fgm 7-8% (7).
cfm (6) isp m fm gz 50,3%z; m h (j, ) 15,3%, mf 15,3%, 17,2%. l z m f (m, mm)
7/22/2019 3514-Ghid Inv Phh
70/252
68 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
f hg 30,1%. cfm , m isp f m, z isp 89,7% z f f z.
.. (2003) b m m fm m-f isp . d 2726 m isp m 605 z (22,80,8%). c f f 1,8 m m (390 64,52,0%),
m (215 35,52,0%), p
7/22/2019 3514-Ghid Inv Phh
71/252
9
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
Bibliograa
1. Faro S. Postpartum endometritis Infections in Pregnancy. Wiley-Liss, New-York, 1990, p. 45.
2. Genchikov L.A. et al. Current prophylaxis of nosocomial infections of neonates and puerpe-
rae. ZhMEI 3, 103-105 (1996). Cit.: . . . 2- .,
2003, . 229.
3. Musina L-T. Et al. Etiology and nosology of nosocomial pyoinammatory diseases in neonates.Rossiiskii Vestnik Perinatologii i Pediatrii 1, 39-42 (1995) Cit.: .
. . 2- ., 2003, . 229.
4. Prisacari V., Plop T. Unele aspecte epidemiologice n infeciile septico-purulente nosocomiale.
Anale tiinice USMF N. Testemianu, vol. 2, Chiinu, 2001. P. 211-215.
5. .., .., ..
. ,
. -, 2003, . 167-169.
6. .., .., ..
-
. .: ,
. .-, 2003, . 64-66.
7. .., .. . .:
. . .. , .. . ., 1993, . 103-110.
8. .. . . .
. .-. .
. , 2006, . 63-67.
9. . .
. . ., 2- . ., 2003. 478 .
10. .., ..
. .:
, . .-,2003, . 59-61.
11. .. -
. ,
. .-, 2003, . 132-133.
12. .., .., ..
- . .
, , , . .,
1999, . 172-173.
2.5 Alte infecii nosocomiale2.5.1 Infecia pediatric
if m z m z mm. p, m , g z f, z z m, z f. e-g f m z , g gmf f f, g g, , fg,. ag m m m f .
m, f x , z
gm z. c x m m g .d xm, f s m shy m , z m , -
7/22/2019 3514-Ghid Inv Phh
72/252
70 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
m. t f f m g f, m f z, f m .
if m mf f fm , f-, m, m, . n f x f . m
fm mf f m . u -mg z h mm m (Hvb, Hvc Hvd).
p f m g m f mf , fz m z z m, f mm mmg, m - f z mm .
c f , gh f m , z m m. M m , m z f m, z g (f x ), mmg m gz
f m, m gm f, . z m m m f m, zg m. p m hg m, f -m. m, f m m f g g, . f m m , z z, m m, , f g , . a, g g f. m m gmf f m. o m mm , z f , .
o g, z f m s -hm, fm m z f m gm. 1950 1960 s g m 1 f g . u, gm-g z mj f m. m m, s.mm 1 2.000 - z f m . sh , g b - f m. F g fz fg z m.
s u am, 2 6% z
f m. r f z , f m -gh . s m m m f m z, m m m g m- m g . p m, f m m . c m g , m gz m m z. r f m g . pm g 500 1.000g m , f x m f x.
F m , z z g z . m, gz-g m , m z m. s g b, s. , m, g
m g. c m gm gm-g : ehh , e . K m. rz m j . t- s. z -mz f m m-z. vm
7/22/2019 3514-Ghid Inv Phh
73/252
1
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
z -mz. rz xm z gm-g. F z m z, z f m .u xm z cm f m f m . l mmm, fg ( mg h
) g m g f m. c m m f m h ( g ), m . if m ( g) (-- -). c m m z, m m.l m - m.
p f m f , f g f . m x f m (bda), z m , f , m - m gh gm m . t, m f bda
m z f.if 0,5-5% . c , f m, f z 3, , z , m- f m f. F z f m (f m), g , f , - z, z g, h, hm, m mm gz, , , m z gm z m, m - zh- hmz - z - hm - g, m - m, f m -, m m, m m -, f fg, sida, h, g, z gm-g.
if , , m z m g m. af, sua, 25% m g m m 1.500 gm, z f . if z m -, m m m. m, g zz m m m -z, m, f f . , g g , 40% z h-m g. , m m, f - m m
m. af, gm , , z z m m z, 25% m-z z m, fm, m, m f gm m m.
s m , fm gm, hm z z, mz f , z g, y z, , j.
if - m m m. M z m, xm - g f.
if f m,
z 40% , , m , m g m m. a f m m x : , , f, g g ,
7/22/2019 3514-Ghid Inv Phh
74/252
72 ediia i
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
m , z . p m m j z m g, f z , z f m . ag zz f z f m, f f, f m m. d f z f, . M mj f m g
e, , pm. sg m f z m m j. i mg z m f m.
d m - m m , m f m bda m. g bda m f g g, gehh, sm, shg, mgm g m g K, e-, c, . if e., g, mf f . cfm , f m f z m ( gj, mm, .),z- h m. Fm mf f
m f g, fm g, z . cz f m bda, -m g sm shg, g , f g z f m m (1 6 ). a f m m gm f - m m h.
r m f m m m m mgm . sgh f m g f g m- x gj m. a m , m f m. m mf m z m - f m f . am m- g f m ff , m m f m.
Bibliograe
1. a h mx mg: .WHo. 20 a 1211 G 27 swz
2. a f m http://www.raa.ro/evenimentestiintice/hi-vacademy/resurse/OrdMS994/ANEXAIIATRIBUTII.doc3. bm o. if g//pg, i, 2001, www..m.//.hm
4. s d. n gh mgm m m www.m./_/m//2006/n%20gh%20%20mgm%20%20m%20m.f
5. .., .., .. . -
. //, , 1985, . 3-6.
6. .. .
, , . ., 1994.
7. .. //
. 07/ 2/2005.8. .. //
. .2007.
7/22/2019 3514-Ghid Inv Phh
75/252
73
GHID DE SUPRAVEGHERE I CONTROL N INFECIILE NOSOCOMIALE
ediia i
2.5.2 Tuberculozan g x m Mycobacteriumtuberculosis m.M.tuberculosis m
m , tb . d g,M.tuberculosis m g f. if
M.tuberculosis , z, - h, jg .
l 2-12 m f, m mz m f, z mg tb z. t, m , m m . a fz tb. p- tb z z m- (ppd), z mm tb g.
axm 5-10% f M.tuberculosis tb , m tb . r tb tb mj m f (1,2,3).
Persoanele expuse riscului major de infectare cu M. tuberculosis f g x f M.tuberculosis
g . p x M.tuberculosis f m concentraiapicturilorinfecioaserspnditenaeridurataexpuneriifadeopersoancuTB.c m g , m m f.
c z - h g ( z m m ) m tb m (4). u tb gz tb - m -tb. g, tb z m m 3 (4,5).
a , m x g x m-j f M.tuberculosis.p g .
t m fm m, m f M.tuberculosis(1). p f Hiv m f f M.tuberculosis x m m hz tb, m - f , Hiv (4,7,8,9).
v bcG fz f x, tb m tb, m f m mg - (10).
Riscul de infectare cu M. tuberculosis n cadrul spitalelor
tm M.tuberculosis mj (12,13,14). p z f , g , tb m, m m mz tb. tm M.tuberculosis f - tb, m z